Disease Control Data, Ankylosing Spondylitis
Descrição
Ankylosing spondylitis: an autoimmune or autoinflammatory disease?
What Are the Causes of Ankylosing Spondylitis?
Intestinal Research
Racial Differences in Clinical Features and Comorbidities in Ankylosing Spondylitis in the United States
ANKYLOSING SPONDYLITIS WINS BENEFITS - Cannon Disability Law
Arthritis Statistics by State
Ankylosing Spondylitis Facts: 17 Things to Know About AS
Ankylosing Spondylitis / Spondyloarthritis - Biomedcode
Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial - The Lancet
RACGP - Ankylosing spondylitis: an update
Upadacitinib 15 mg sustains efficacy through 1 year in ankylosing spondylitis
Demographic data for ankylosing spondylitis patients and healthy controls
de
por adulto (o preço varia de acordo com o tamanho do grupo)
)
